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novel reimbursement schemes for other branded products.CONCLUSIONS:Cancer
drug reimbursement models are setting new benchmark for payers to manage
access and control costs. These models have significant implications for other
expensive branded products.
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OBJECTIVES: 1) Assess the current status of data disclosure in terms of Medicines
Registration and Quality Assurance, Availability of Medicines, Price of Medicine
and Polices and Practices concerning the promotion of medicines in Jordan; 2)
Disclose the currently available data; 3) Identify where there are gaps in
information. METHODS: Using data disclosure survey tool developed by WHO col-
laborating center in pharmaceutical policy under the Medicines Transparency In-
tiative that was implemented in Jordan(2008-2009). RESULTS: The disclosure sur-
vey results showed that only 20% of the key disclosure data around the four key
MeTA components is available and publicly disclosed, while 60% is available but
not publicly disclosed and 20% is not available. Most of the unavailable data was
related to medicines promotion and standard treatment guidelines polices and
practices. Most of polices/laws, regulations, and practices covering medicines reg-
istration, quality assurance and pricing are available, disclosed and enforcing by
law. The data disclosure process highlightined some challenges in the availability
and access to information such as limited access to some data due to requirement
of fees and limited engament of the private sector in disclosing data especially
when it comes to utilizationa nd expenditure data. CONCLUSIONS: 1) To work on
establishing a national committee with authority to monitor adherence to phar-
maceutical promotion codes of ethics; 2) To work with related parties on establish-
ing a national committee to develop evidence based standard treatment guide-
lines; 3) To work with health authorites such as the JFDA to improve accessibility to
important data such as updated medicines prices and registration status; and 4) To
establish a montoring system in collaboration with related stakholders to update
and review the disclosure status in Jordan regularly in order to monitor progress
through classifying data into A, B, and C categories A: available and publicly dis-
closed B: Available C: Not Available.
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OBJECTIVES: Since 2006, data on migration status is collected through representa-
tive survey in Chile (CASEN-survey). In this survey, around 1% reported being in-
ternational immigrants in this survey; however, 0.67% preferred not to report their
migrations status. This study aimed at exploring the living conditions and health
status of migration status missing values (MS-MV) and compare them to self-re-
ported immigrants in this survey. METHODS: Design: Cross-sectional analysis of
population-based CASEN survey-2006 in Chile (268,873 participants). This analysis
focuses on the 0.67% that did not respond the question on migration status (MS-
MV) (n1577) versus self-reported international immigrants (n1877). Six health
outcomes: any disability (dichotomous), any health problem/accident (AHPA), any
hospitalization/surgery (AHS), any chronic condition/cancer (ACCC), and any med-
ical and emergency attentions. Living conditions: Demographic factors (age, sex,
marital status, urban/rural), socioeconomic status (household income per capita,
employment status and educational level), and material standards (overcrowding,
sanitation index, housing quality standards). Weighted crude and adjusted regres-
sion models were conducted in STATA 10.0.RESULTS:The MS-MV has a higher rate
of children, especially with an ethnic background, and people living in rural set-
tings than immigrants. They show a lower SES (income, education and type of
occupation) and poorer material living conditions than immigrants. The MS-MV
show a higher rate of emergency attentions received in the past month, disability,
and AHS than immigrants. Other health events were not different between these
two population groups. CONCLUSIONS: The MS-MV represents a complex group,
affected by socioeconomic deprivation. Some of them may be undocumented im-
migrants, but there is little direct evidence to support this. Regardless of their
migration status, this is a vulnerable group that needs special consideration in
Chile. Equity-centred policy interventions in Chile should focus on improving the
living standards and protecting the health of those were categorised into this
group, particularly the children.
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OBJECTIVES: Accessibility to pharmacy, including geographic accessibility, is an
important goal every government tries to meet. In this study, we analyze the geo-
graphic distribution and accessibility of pharmacies in the municipal territory of
Qom (a province in Iran) for both pedestrians and drivers. METHODS: The percent-
age of households living at specific distances (150, 300, 450, 600 and 750 meters)
from one pharmacy was calculated using geographic information system (GIS)
capabilities. The analysis was performed a second time for 24-hour, 7-day phar-
macies (with 1, 2 and 3 kilometers distance) to evaluate geographic pharmacy
accessibility during holidays, on weekends, and at night. The maximum acceptable
distances for appropriate geographic pharmacy accessibility in normal days and on
holidays (and weekends) were considered 750 meters and 3 kilometers,
respectively. RESULTS: Our analysis indicated that in normal days about 88% of
households living in Qom have acceptable pedestrian accessibility, and almost all
households have acceptable driving accessibility to a pharmacy. In terms of geo-
graphic accessibility to 24-hour, 7-day pharmacies, the results showed that less
than 30% and 95% of households, have acceptable pedestrian and driver accessi-
bility, respectively. CONCLUSIONS: The geographic accessibility of pharmacies at
night and on holidays has to be addressed by provincial health policymakers. keep-
ing a pharmacy opened during holidays and at nights in the areas 24-hour, 7-day
pharmacy accessibility is poor and also offering financial incentives for pharmacies
to be established in low access areas could be considered as a short term solution.
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EXCESS WEEKEND MORTALITY IN HOSPITALS: A RESULT OF HIGHER SEVERITY
OF ILLNESS AT THE TIME OF ADMISSIONS?
Paudyal P1, Shepheard-Walwyn T2, Gericke CA1
1Peninsula Medical School/National Institute for Health Research, Plymouth, Devon, UK,
2Lightfoot Solutions UK Limited, Bracknell, Berkshire , UK
OBJECTIVES: To examine the relationships between urgent care activity and mor-
tality among patients admitted to hospital on weekends compared to weekdays.
METHODS: A retrospective analysis was performed of all emergency acute care
admissions in England between April 2009 and March 2011 using National Health
Service Hospital Episode Statistics data. Hospital mortality among patients admit-
ted on weekends as compared to weekdays was analysed using the following mea-
sures; (1) overall deaths; (2) deaths within and after three days of admission (3)
deaths among patients with higher risk conditions and lower risk conditions. The
higher risk conditions consisted of 103 Primary Diagnosis codes (ICD-10) which
accounted for 74% of hospital deaths in England; the remaining codes were cat-
egorised as lower risk conditions. RESULTS: There were 10,221,500 emergency hos-
pital admissions during the two-year study period; 23.8% of the patients were
admitted on weekends. A total of 391,938 patients died in hospital. Weekend ad-
mission was associated with significantly higher mortality as compared to week-
day admission (Odds Ratio 1.11, 95% CI 1.10-1.12). Mortality within three days of
admission (early deaths) was also higher for patients admitted on weekends (OR
1.16, 95%CI (1.14-1.17) and this difference persisted for both higher and lower risks
conditions. However, when early deaths were excluded from the analysis, mortal-
ity was not affected by weekend admission. CONCLUSIONS: As mortality after
three days of admission was not affected by weekend admission, it is probable that
the weekend admission effect on mortality is largely due to higher disease severity
at admission on weekends rather than a consequence of shortfalls in quality of
care on weekends as postulated in previous studies.
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OBJECTIVES: The Affordable Medicines Facility – malaria (AMFm) is a financing
mechanism designed to make artemisinin-based combination therapies (ACTs) a
more accessible treatment for malaria(Laspinall 2008). This study assessed the
deployment of ACTm in southern Ghana. METHODS: The study made a census of
functional pharmacies, licensed chemical shops and private health facilities in the
southern part of Ghana. Structured questionnaires were used to interview atten-
dants at the facilities on knowledge, availability; cost, patronage of the ACTm and
training about the program. RESULTS: Overall, 78% of the facilities stocked the
ACTm. Dome had 86.5% and Taifa, 71.1%. The cost per treatment of ACTm ranged
between GHC 1.00-6.00(0.66-3.96USD). Whilst 59.2% sold ACTm within the recom-
mended range (GHC 1.00-1.50), 40.8% sold it between GHC 2.00-6.00(1.32-3.96USD).
At Dome, cost range was GHC 1.00-6.00 with GHC 2.45(1.62USD), and 2.00(1.32USD)
as the mean and median prices. Taifa, had range GHC 1.00-4.00, with GHC 1.50 as
mean and GHC 1.70(1.12USD) as the median prices. While at Taifa 78.1% of ACTm
stocked facilities sold it between GHC 1.00-1.50, only 40.6% did so at Dome (p-value
less than 0.001). Seventy seven percent of respondents had good knowledge of the
program. The main channels of communication were audio and visual. Thirty
seven percent of respondents were trained about the program. Whilst 96.3% of the
trained stocked ACTm, 67.5% of untrained stocked the drugs (p-value  0.001).
Majority (93.3 %) of the trained preferred ACTm first choice antimalarial, to non-
ACTm, compared to 50% of untrained (p-value  0.001). Overall, 62.2% of respon-
dents reported good patronage. CONCLUSIONS: The results underscore initial ob-
servation that knowledge and availability of ACTm was poor. The ACTm though
well deployed in the southern Ghana, it is more financially accessible in Taifa than
the Dome sub-district hence, difference in patronage.
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OBJECTIVES: Estimate the effect of changes in government pricing and reimburse-
ment regulations on the Turkish pharmaceutical industry. Five different product
groups within the pharmaceutical industry between 2004 and 2011 were studied.
METHODS: Five product groups were examined: original products without gener-
ics, original products with generics, generics, 20-year-old generics, and 20-year-old
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